pubmed-article:8051542 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8051542 | lifeskim:mentions | umls-concept:C0000981 | lld:lifeskim |
pubmed-article:8051542 | lifeskim:mentions | umls-concept:C0003286 | lld:lifeskim |
pubmed-article:8051542 | lifeskim:mentions | umls-concept:C0009968 | lld:lifeskim |
pubmed-article:8051542 | lifeskim:mentions | umls-concept:C1704241 | lld:lifeskim |
pubmed-article:8051542 | lifeskim:mentions | umls-concept:C0871161 | lld:lifeskim |
pubmed-article:8051542 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:8051542 | pubmed:dateCreated | 1994-9-6 | lld:pubmed |
pubmed-article:8051542 | pubmed:abstractText | Two copper acetazolamide complexes were synthesized for evaluation as anticonvulsant agents. These complexes were found to be more effective as anticonvulsants than the acetazolamide. | lld:pubmed |
pubmed-article:8051542 | pubmed:language | eng | lld:pubmed |
pubmed-article:8051542 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8051542 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8051542 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8051542 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8051542 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8051542 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8051542 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8051542 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8051542 | pubmed:month | Aug | lld:pubmed |
pubmed-article:8051542 | pubmed:issn | 0162-0134 | lld:pubmed |
pubmed-article:8051542 | pubmed:author | pubmed-author:SorensonJ RJR | lld:pubmed |
pubmed-article:8051542 | pubmed:author | pubmed-author:FerrerSS | lld:pubmed |
pubmed-article:8051542 | pubmed:author | pubmed-author:BorrásJJ | lld:pubmed |
pubmed-article:8051542 | pubmed:author | pubmed-author:AlzuetGG | lld:pubmed |
pubmed-article:8051542 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8051542 | pubmed:day | 1 | lld:pubmed |
pubmed-article:8051542 | pubmed:volume | 55 | lld:pubmed |
pubmed-article:8051542 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8051542 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8051542 | pubmed:pagination | 147-51 | lld:pubmed |
pubmed-article:8051542 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:8051542 | pubmed:meshHeading | pubmed-meshheading:8051542-... | lld:pubmed |
pubmed-article:8051542 | pubmed:meshHeading | pubmed-meshheading:8051542-... | lld:pubmed |
pubmed-article:8051542 | pubmed:meshHeading | pubmed-meshheading:8051542-... | lld:pubmed |
pubmed-article:8051542 | pubmed:meshHeading | pubmed-meshheading:8051542-... | lld:pubmed |
pubmed-article:8051542 | pubmed:meshHeading | pubmed-meshheading:8051542-... | lld:pubmed |
pubmed-article:8051542 | pubmed:meshHeading | pubmed-meshheading:8051542-... | lld:pubmed |
pubmed-article:8051542 | pubmed:meshHeading | pubmed-meshheading:8051542-... | lld:pubmed |
pubmed-article:8051542 | pubmed:meshHeading | pubmed-meshheading:8051542-... | lld:pubmed |
pubmed-article:8051542 | pubmed:meshHeading | pubmed-meshheading:8051542-... | lld:pubmed |
pubmed-article:8051542 | pubmed:meshHeading | pubmed-meshheading:8051542-... | lld:pubmed |
pubmed-article:8051542 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:8051542 | pubmed:articleTitle | Anticonvulsant properties of copper acetazolamide complexes. | lld:pubmed |
pubmed-article:8051542 | pubmed:affiliation | Department of Inorganic Chemistry, Fac. Farmacia, Univ. Valencia, Spain. | lld:pubmed |
pubmed-article:8051542 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8051542 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:8051542 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:8051542 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |